drugset / Trial / NCT06223841
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of IAP0971 in Patients with Advanced Malignant Tumors.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2026-03-01
- Completion
- 2027-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IAP0971 | Unknown | — | Subcutaneous |